Showing 1 to 10 of 27 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
An Open-label, Multi-center, Phase I Study of Oral IAG933 in Adult Patients With Advanced Mesothelioma and Other Solid Tumors
CIAG933A12101 NCT04857372  Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Mesothelioma Solid Tumors |
Dr. Marie Florescu Adeline Hamon 514-890-8000 poste 30737 |
|
Phase I Trial of PCLX-001 in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma and Advanced Solid Malignancies
PCLX-001-01 NCT04836195 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Non-Hodgkin's Lymphoma Solid Tumors |
Dr. Rahima Jamal Adeline Hamon 514-890-8000 poste 30737 |
|
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR): A Phase II Basket Trial
CAPTUR/PM.1 NCT03297606 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Solid Tumors |
Dr. Cristiano Ferrario Inna Zhylina 514-340-8222 poste 28437 |
|
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
GARNET NCT02715284 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Solid Tumors |
Dr. Lucy Gilbert Phuong-Nam (Nathalie) Nguyen 514-934-1934 poste 31975 |
|
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
GARNET NCT02715284 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Solid Tumors |
Dr. Vanessa Samouëlian Shirley Truchon 514-890-8000 poste 25350 |
|
A Phase 1 Study of [225Ac]-FPI-1434 Injection in Patients With Advanced Solid Tumours
FPX-01-01 NCT03746431 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Solid Tumors |
Dr. Fred Saad Amal Nadiri 514-890-8000 poste 26074 |
|
A Multicenter, Open Label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial
MK-3475-587 NCT03486873 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Solid Tumors |
Dr. Diane Provencher France Gauthier 514-890-8000 poste 30921 |
|
Phase Ib Expansion Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
CX-5461-04 NCT04890613 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Solid Tumors |
Dr. Diane Provencher Adeline Hamon 514-890-8000 poste 30737 |
|
A Modular Phase I/IIa, Open-label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Ascending Doses of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
PETRA NCT04644068 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Solid Tumors |
Dr. Diane Provencher Fanny Helmer 514-890-8000 poste 17825 |
|
A Phase 1/2 Study of BMS-986340 as Monotherapy and in Combination With Nivolumab in Participants With Advanced Solid Tumors
CA052-002 NCT04895709 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Solid Tumors |
Dr. Rahima Jamal Adeline Hamon 514-890-8000 poste 30737 |
Groupe d'étude en oncologie du Québec